A sugar switch for anti-inflammatory antibodies (Q79222449)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

A sugar switch for anti-inflammatory antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Roy Jefferis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

1230-1231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt1006-1230

20 December 2019

exact match

0 references

cites work

Designing antibodies for oncology

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Glycosylation of recombinant antibody therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Fcgamma receptors: old friends and new family members

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Humanization of yeast to produce complex terminally sialylated glycoproteins

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II.

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

The 3.2-A crystal structure of the human IgG1 Fc fragment-Fc gammaRIII complex

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity

1 reference

https://api.crossref.org/works/10.1038%2FNBT1006-1230

7 January 2021

Identifiers

DOI

10.1038/NBT1006-1230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17033662%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference